ISEC Healthcare Ltd.

Catalist:40T Stock Report

Market Cap: S$227.2m

ISEC Healthcare Past Earnings Performance

Past criteria checks 4/6

ISEC Healthcare has been growing earnings at an average annual rate of 21.1%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 16% per year. ISEC Healthcare's return on equity is 15.4%, and it has net margins of 19.3%.

Key information

21.1%

Earnings growth rate

17.0%

EPS growth rate

Healthcare Industry Growth9.7%
Revenue growth rate16.0%
Return on equity15.4%
Net Margin19.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How ISEC Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

Catalist:40T Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 247214130
30 Jun 247113130
31 Mar 247013120
31 Dec 237013120
30 Sep 237013120
30 Jun 236913120
31 Mar 236814110
31 Dec 226313100
30 Sep 225912100
30 Jun 2249990
31 Mar 2243890
31 Dec 2140790
30 Sep 2137680
30 Jun 2140780
31 Mar 2136580
31 Dec 2036580
30 Sep 2038690
30 Jun 2037590
31 Mar 2042790
31 Dec 1943790
30 Sep 1942780
30 Jun 1941780
31 Mar 1941980
31 Dec 1840880
30 Sep 1839880
30 Jun 1839980
31 Mar 1838880
31 Dec 1737870
30 Sep 1736770
30 Jun 1733770
31 Mar 1732770
31 Dec 1631670
30 Sep 1629570
30 Jun 1628470
31 Mar 1627470
31 Dec 1527370
30 Sep 1527280
30 Jun 1526280
31 Mar 1524270
31 Dec 1422260
30 Sep 1419340
31 Mar 1418330
31 Dec 1318330

Quality Earnings: 40T has high quality earnings.

Growing Profit Margin: 40T's current net profit margins (19.3%) are higher than last year (19.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 40T's earnings have grown significantly by 21.1% per year over the past 5 years.

Accelerating Growth: 40T's earnings growth over the past year (4%) is below its 5-year average (21.1% per year).

Earnings vs Industry: 40T earnings growth over the past year (4%) exceeded the Healthcare industry -26%.


Return on Equity

High ROE: 40T's Return on Equity (15.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies